Cormorant Asset Management, LP Monte Rosa Therapeutics, Inc. Transaction History

Cormorant Asset Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$6.71 - $9.72 $671,000 - $972,000	-100,000 Reduced 3.34%	2,893,717 $22 Million
Q2 2022 Aug 15, 2022	SELL	$6.15 - $14.99 $52,164 - $127,145	-8,482 Reduced 0.28%	2,993,717 $28.9 Million
Q4 2021 Feb 14, 2022	SELL	$16.28 - $27.15 $1.63 Million - $2.72 Million	-100,000 Reduced 3.22%	3,002,199 $61.3 Million
Q3 2021 Nov 15, 2021	SELL	$18.59 - $42.21 $1.71 Million - $3.87 Million	-91,774 Reduced 2.87%	3,102,199 $68 Million
Q2 2021 Aug 16, 2021	BUY	$18.86 - $22.7 $60.2 Million - $72.5 Million	3,193,973 New	3,193,973 $69.6 Million

43.9M

141K

31.2K

Ticker GLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,713,900
Market Cap $329M
Description
Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing prot...

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Cormorant Asset Management, LP with notifications on news.